|
Index of reports
> Cases with Sepsis ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Thalomid side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)
Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2008-09-04
End date: 2009-12-14
Melphalan Hydrochloride
Dosage: 9 milligram/sq. meter
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-21
Prednisone TAB
Dosage: 100 milligram
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-19
End date: 2011-07-26
Other drugs received by patient: Dexamethasone; Simvastatin; Garlic; Dilaudid; Pseudoephedrine HCL; Loperamide; Proair HFA; Talwin NX; Vitamin D; Ambien; Duragesic-100; Antacid Medicine (Homeopathic); MS Contin; Vitamin E; Magnesium Oxide; Aspirin; Neupogen; Miralax; Vitamin B-12
Possible Thalomid side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)
Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 9 milligram/sq. meter
Start date: 2008-09-04
End date: 2009-12-14
Prednisone TAB
Dosage: 100 milligram
Start date: 2008-09-04
End date: 2009-12-14
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-21
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-19
End date: 2011-07-26
Other drugs received by patient: Antacid Medicine (Homeopathic); Aspirin; Loperamide; Garlic; Miralax; Ambien; Dilaudid; Vitamin E; Simvastatin; Proair HFA; Duragesic-100; Dexamethasone; Neupogen; Vitamin B-12; Vitamin D; Talwin NX; MS Contin; Pseudoephedrine HCL; Magnesium Oxide
Possible Thalomid side effects in 73 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)
Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-04-19
End date: 2011-07-26
Melphalan Hydrochloride
Dosage: 9 milligram/sq. meter
Start date: 2008-09-04
End date: 2009-12-14
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-21
Prednisone
Dosage: 100 milligram
Start date: 2008-09-04
End date: 2009-12-14
Other drugs received by patient: Loperamide; Aspirin; Dexamethasone; Duragesic-100; Vitamin B-12; Proair HFA; Garlic; Miralax; Vitamin E; Pseudoephedrine HCL; Dilaudid; Neupogen; Talwin NX; Antacid Medicine (Homeopathic); Vitamin D; MS Contin; Simvastatin; Magnesium Oxide; Ambien
Possible Thalomid side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-08
Patient:
Reactions: Neuropathy Peripheral, Pneumonia, Diabetes Mellitus, Sepsis, Anaemia, Neutropenia, Thrombocytopenia, Disease Progression, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Thalomid
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Bortezomib
Vincristine
Indication: Multiple Myeloma
Adriamycin PFS
Indication: Multiple Myeloma
Other drugs received by patient: Aspirin; Neupogen; Melphalan Hydrochloride
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-01-24
Patient: female
Reactions: Sepsis, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-01
End date: 2011-06-01
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2011-06-01
End date: 2011-01-01
Possible Thalomid side effects in female
Reported by a physician from United States on 2011-12-19
Patient: female
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-01
Thalomid
Dosage: 50 milligram
Administration route: Oral
Start date: 2011-06-01
|
